Pathology Diagnostics Ltd is an independent GCLP accredited histopathology research organisation delivering high-quality tissue laboratory & diagnostics services to industry Research & Development scientists engaged in drug and biomarker development.
Since our establishment, we have achieved the following recognition:
- 2013 EU FP7 Grant Winner, European consortium Cancer biomarker discovery & validation
- 2012 TSB Biomedical Catalyst Award winner
- 2011 Cambridgeshire/EEDA High Growth Coaching Scheme Award
- 2010 Finalist, UK Medilink Awards
- 2009 Winner, ERBI Best Biotech/Medtech Start-up Award
- 2008 Winner, EW Eastern Region Innovation/Science & Technology Award
At Pathology Diagnostics Ltd we realise that our clients’ satisfaction is paramount. A selection of real feedback from our clients:
It has been a pleasure to work with Pathology Diagnostics Ltd. and very rewarding because of your high competence. Thank you very much!
If you would like further information, please contact us.
White Paper: The Use of Immunohistochemistry in Biomarker Research and Clinical Trials
Cancer Awareness Open Day
Pathology Diagnostics Ltd exhibit at the EPIC Biotech Conference in London
One Nucleus: Life Science Leadership Series - Personalised Medicine
DakoLink-UP Scientific Symposium 2014 - Reducing Uncertainty in Histopathology
Advances in Research and techniques 2013: Cutting edge histopathology in research and diagnosis report covering the areas of in situ hybridization...
EORTC breaking news: triple therapy with encorafenib, cetuximab +/-alpelisib shows promising results in BRAF mutation positive CRC #ENA2014
Royal College of Optahlmologists calls for NHS to use Avastin instead of Lucentis for agerelated macular degeneration http://t.co/WGKSqO6kIM